These changes in children may compromise visual acuity and lead to amblyopia. At 1 month follow-up the patient had decreased photophobia but a persistent phlyctenule. Treatment continued for an additional 6 weeks, with reduction in inflammation and vascularization of the phlyctenule. Loteprednol was slowly discontinued, Azithromycin was reduced to every other day, and cyclosporine ophthalmic drops, 0.05% (Restasis; Allergan, Irvine, CA), twice daily, were added to the left eye.
Ten weeks later, 4 weeks after running out of his medications, the patient returned with left eye discomfort and hyperemia. Examination showed injection and corneal opacification in his left eye. He was again started on loteprednol drops 3 times daily in the left eye. tapered off over 3 weeks, cyclosporine ophthalmic drops twice daily in the left eye, and oral azithromycin 100 mg daily for 2 months. At follow-up 4 and 10 months later, he had no eye complaints and examination showed a small corneal scar in the left eye, with no signs of active phlyctenulosis. 
Discussion
Blepharokeratoconjunctivitis is underdiagnosed in children. 3 A stepwise approach to treatment begins with lid hygiene followed by topical antibiotics such as erythromycin or bacitracin ointments.. 4 If still present oral doxycycline is used in adults, but its side effects in children, most notably tooth discoloration, restrict its use.
5
In children, oral erythromycin therapy is a proven and effective option; however, it needs to be dosed multiple times daily. 6 As an alternative, we examined oral azithromycin. Whereas oral azithromycin is reported to be effective in the treatment of posterior blepharitis in adults, the data on its use in children is limited. 7 While having the same mechanism of action as erythromycin, azithromycin has improved oral bioavailability, longer half-life (allowing once daily dosing), higher tissue concentrations, enhanced microbial activity, and reduced gastrointestinal side effects 8 : the most common macrolide side effects are experienced half as often with azithromycin. 9 The cost of an erythromycin regimen (150 mg daily) of 8 months duration is approximately $400
whereas an azithromycin regimen (125 mg daily) for 3 months may cost twice as much.
While further studies are needed, these 3 cases suggest a positive effect of oral azithromycin in the treatment of persistent BKC in children. Given the inflammatory nature of the disease, we combine azithromycin with anti-inflammatory therapy using short-term steroids and long-term cyclosporine drops. Although this combined therapy clouds the exact effect of oral azithromycin, given its simplier dosing and better tolerance, azithromycin appears to be a possible substitute for oral erythromycin in persistent BKC.
